Form 8-K · Current report
Lennox International 8-K, filed Sep 18, 2026
- Filed
- CIK
- 0001069202
- Accession no.
- 0001069202-26-000091
Summary
Lennox International's Compensation and Human Resources Committee approved a new form of Long-Term Incentive Award Agreement for U.S. employees at vice president level and above, to be used for grants of restricted stock units, performance share units, and stock appreciation rights under the company's 2019 Equity and Incentive Compensation Plan. The terms are substantially similar to the previously disclosed form, with updates to vesting and exercise schedules and retirement eligibility.
Key points
- The committee approved the new award agreement on September 16, 2026.
- The agreement covers grants to executive officers of restricted stock units, performance share units, and stock appreciation rights.
- The form is attached as Exhibit 10.1 to the Form 8-K.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
- 9.01Financial Statements and Exhibits
From the filing
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On September 16, 2026, the Compensation and Human Resources Committee (the “Committee”) of the Board of Directors of Lennox International Inc. (the “Company”) approved a new form of Long-Term Incentive Award Agreement for U.S. Employees - Vice President and Above for use under the 2019 Equity and Incentive Compensation Plan (the “Award Agreement”). The Award Agreement will be used for grants to executive officers of restricted stock units, performance share units, and stock appreciation rights. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.